AKBA - Akebia Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
292.16%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 236.2 | 160.2 | 194.6 | 292.5 | 211.7 | 294.6 | 335.0 | 207.7 | 178.0 | 1.5 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 39.5 | 63.2 | 74.1 | 22.5 | 81.5 | 64.0 | 145.3 | 7.7 | 0.6 | 115.8 | 0.1 | 23.3 | 0 | 0 |
| Gross Profit | 196.7 | 97.0 | 120.5 | 270.0 | 130.2 | 230.7 | 189.7 | 200.1 | 177.4 | (114.2) | (0.1) | (23.3) | 0 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 62.4 | 37.7 | 63.1 | 166.0 | 147.9 | 218.5 | 323.0 | 291.1 | 230.9 | 115.8 | 43.0 | 25.4 | 10.8 | 5.6 |
| SG&A Expenses | 107.5 | 106.5 | 100.2 | 138.6 | 174.1 | 154.1 | 149.5 | 87.1 | 27.0 | 22.2 | 18.5 | 12.5 | 5.2 | 2.9 |
| Other Expenses | 3.4 | 3.3 | 3.4 | 46.2 | 72.7 | 235.9 | 3.5 | 0 | 0.2 | (0.2) | 0.3 | 0.7 | 0 | 0 |
| Operating Expenses | 173.2 | 147.5 | 166.7 | 350.8 | 394.7 | 608.5 | 476.0 | 378.2 | 257.9 | 138.0 | 61.5 | 37.9 | 15.9 | 8.5 |
| Operating Income | ||||||||||||||
| Operating Income | 23.5 | (50.5) | (46.3) | (80.8) | (264.5) | (377.8) | (286.3) | (178.1) | (79.9) | (136.5) | (61.5) | (37.9) | (15.9) | (8.5) |
| Interest Expense | 24.2 | 18.2 | 6.0 | 15.7 | 19.9 | 8.9 | 1.4 | 0 | 0 | 0 | 0.5 | 0.2 | 0.7 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 2.2 | 6.2 | 2.8 | 0.9 | 0 | 0 | 0 | 1.6 |
| Profitability | ||||||||||||||
| EBITDA | 21.7 | (13.7) | (8.3) | 3.1 | (189.9) | (139.8) | (249.9) | (178.1) | (76.1) | (136.2) | (61.4) | (37.9) | (12.5) | (6.6) |
| EBIT | 20.5 | (51.2) | (45.9) | (34.6) | (227.9) | (174.5) | (286.3) | (178.2) | (76.7) | (136.5) | (61.5) | (37.9) | (15.9) | (6.6) |
| Income Before Tax | (3.7) | (69.4) | (51.9) | (94.2) | (282.0) | (384.8) | (286.3) | (171.9) | (76.9) | (135.7) | (60.7) | (37.0) | (13.2) | (8.2) |
| Income Tax Expense | 1.6 | 0 | 0 | 0 | 0 | 0 | (6.6) | (28.3) | (2.8) | (0.9) | (0.5) | (0.2) | 0 | 1.6 |
| Net Income | (5.3) | (69.4) | (51.9) | (94.2) | (282.0) | (384.8) | (279.7) | (171.9) | (76.9) | (135.7) | (60.7) | (37.0) | (13.2) | (8.2) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -0.02 | -0.33 | -0.28 | -0.58 | -1.48 | -2.53 | -2.36 | -1.47 | -1.77 | -3.60 | -2.29 | -2.40 | -0.68 | -0.81 |
| EPS (Diluted) | -0.02 | -0.33 | -0.28 | -0.58 | -1.48 | -2.53 | -2.36 | -1.47 | -1.77 | -3.60 | -2.29 | -2.40 | -0.68 | -0.81 |
| Shares Outstanding | 257.2 | 210.9 | 187.5 | 182.8 | 165.9 | 138.5 | 118.4 | 116.9 | 43.5 | 37.7 | 26.5 | 15.4 | 14.9 | 10.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 184.8 | 51.9 | 42.9 | 90.5 | 149.8 | 229.1 | 147.7 | 104.6 | 70.2 | 187.3 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 40.0 | 0.2 | 217.0 | 247.6 | 73.0 |
| Net Receivables | 47.0 | 34.4 | 39.3 | 40.3 | 51.6 | 28.6 | 38.9 | 16.7 | 34.2 | 33.8 |
| Inventory | 15.6 | 16.2 | 15.7 | 21.6 | 36.6 | 61.0 | 116.3 | 114.2 | 0 | 0 |
| Other Current Assets | (62.6) | 7.3 | 20.2 | 32.9 | 0 | 12.8 | 6.4 | 15.7 | 6.3 | 0 |
| Total Current Assets | 184.8 | 113.8 | 118.1 | 185.2 | 271.1 | 371.4 | 309.5 | 468.3 | 358.4 | 296.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0 | 10.4 | 16.0 | 34.4 | 40.6 | 35.5 | 39.4 | 8.0 | 3.6 | 2.6 |
| Goodwill | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 55.1 | 55.1 | 55.1 | 0 | 0 |
| Intangible Assets | 0 | 0 | 36.0 | 72.1 | 108.1 | 144.2 | 291.2 | 328.2 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 2.0 | 2.1 | 2.5 | 1.3 | 0 |
| Other Non-Current Assets | 132.7 | 37.4 | 12.4 | 5.4 | 50.4 | 35.9 | 73.9 | 21.8 | 2.3 | 1.3 |
| Total Non-Current Assets | 191.7 | 106.8 | 123.6 | 170.9 | 258.2 | 272.7 | 461.7 | 528.3 | 5.9 | 3.9 |
| Total Assets | 376.6 | 220.7 | 241.7 | 356.1 | 529.3 | 644.1 | 771.2 | 996.5 | 364.2 | 300.2 |
| Current Liabilities | ||||||||||
| Account Payables | 21.2 | 15.2 | 14.6 | 18.0 | 33.6 | 41.3 | 39.2 | 42.8 | 7.0 | 2.0 |
| Short-Term Debt | 40.1 | 4.3 | 19.5 | 32 | 97.5 | 5.3 | 5.0 | 15 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 3.7 | 20.9 | 53.3 | 70.4 | 57.0 | 84.9 | 82.0 |
| Other Current Liabilities | 101.7 | 22.8 | 18.3 | 52.5 | 31.2 | 72.9 | 80.9 | 26.8 | 46.5 | 0.0 |
| Total Current Liabilities | 162.9 | 80.9 | 99.9 | 129.5 | 261.1 | 187.1 | 208.1 | 265.7 | 144.3 | 114.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 176.2 | 175.5 | 71.2 | 34.1 | 0 | 96.4 | 75.8 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.6 | 0.2 | 0 |
| Other Non-Current Liabilities | 4.8 | 9.9 | 49.0 | 115.0 | 139.1 | 63.0 | 31.9 | 32.6 | 2.6 | 2.5 |
| Total Non-Current Liabilities | 181.0 | 188.9 | 172.4 | 221.3 | 194.3 | 209.4 | 168.3 | 94.9 | 100.6 | 117.8 |
| Total Liabilities | 344.0 | 269.9 | 272.3 | 350.8 | 455.3 | 396.5 | 376.4 | 360.6 | 244.9 | 232.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (1,683.7) | (1,678.4) | (1,609.0) | (1,557.0) | (1,462.8) | (1,177.5) | (794.1) | (514.4) | (374.1) | (297.1) |
| Accumulated Other Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | (0.3) | (0.4) | (0.0) |
| Total Stockholders' Equity | 32.6 | (49.2) | (30.6) | 5.2 | 74.0 | 247.6 | 394.8 | 635.9 | 119.3 | 68.1 |
| Total Liabilities & Equity | 376.6 | 220.7 | 241.7 | 356.1 | 529.3 | 644.1 | 771.2 | 996.5 | 364.2 | 300.2 |
| Debt Metrics | ||||||||||
| Total Debt | 216.3 | 188.7 | 104.2 | 99.8 | 136.0 | 126.3 | 108.3 | 15 | 0 | 0 |
| Net Debt | 31.5 | 136.9 | 61.3 | 9.3 | (13.8) | (102.8) | (39.4) | (89.6) | (70.2) | (187.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (5.3) | (69.4) | (51.9) | (92.6) | (282.0) | (383.5) | (279.7) | (143.6) | (76.9) | (135.7) |
| Depreciation & Amortization | 1.3 | 37.5 | 41.8 | 37.7 | 36.1 | 33.6 | 38.6 | 2.4 | 0.6 | 0.3 |
| Stock-Based Compensation | 11.3 | 7.8 | 9.3 | 17.8 | 0 | 24.5 | 11.9 | 19.0 | 8.9 | 5.8 |
| Change in Working Capital | 16.5 | (39.7) | (20.7) | (1.4) | (105.6) | (13.7) | (99.1) | 36.0 | 7.2 | 186.7 |
| Other Non-Cash Items | 44.3 | 23.1 | (1.9) | (34.7) | 98.5 | 24.6 | 77.3 | 17.0 | 4.0 | 0.8 |
| Operating Cash Flow | 68.0 | (40.7) | (23.4) | (73.2) | (253.0) | (110.4) | (257.4) | (97.5) | (56.2) | 57.9 |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.0) | 0 | (0.1) | (0.1) | (0.3) | (6.7) | (1.6) | (1.6) | (2.7) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 39.7 | 0 | 6.1 | 1.6 | 2.7 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | (99.9) | 0 | (224.2) | (330.6) | (147.0) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 40 | 60.2 | 217.8 | 256.3 | 155.0 | 162.4 |
| Other Investing Activities | (7.9) | 0 | 0 | 0 | 0 | (39.7) | 0 | 32.1 | (1.6) | (2.7) |
| Investing Cash Flow | (7.9) | (0.0) | 0 | (0.1) | 39.9 | (40.0) | 211.2 | 36.6 | (177.3) | 12.7 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 4.6 | 7.9 | (32) | (33) | 44.8 | 20.0 | 62.7 | (0.0) | (0.0) | (0.0) |
| Stock Repurchased | 0 | (1.3) | 0 | 0 | 0 | 0 | (0.4) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.1) | 0.4 | 0.0 | 40.1 | 0 | 1.2 | 0.6 | 0.6 | 1.3 | 0.1 |
| Financing Cash Flow | 72.9 | 49.7 | (25.2) | 14.6 | 133.7 | 231.7 | 89.0 | 96.6 | 116.2 | 66.9 |
| Cash Position | ||||||||||
| Net Change in Cash | 133.0 | 9.0 | (48.6) | (58.7) | (79.3) | 81.3 | 42.7 | 35.7 | (117.2) | 137.6 |
| Cash at Beginning | 53.5 | 44.6 | 93.2 | 151.8 | 229.1 | 149.8 | 107.1 | 71.4 | 187.3 | 49.8 |
| Cash at End | 186.5 | 53.5 | 44.6 | 93.2 | 149.8 | 231.1 | 149.8 | 107.1 | 70.2 | 187.3 |
| Free Cash Flow | 68.0 | (40.7) | (23.4) | (73.3) | (253.0) | (110.7) | (264.1) | (99.1) | (57.8) | 55.2 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 236.2 | 160.2 | 194.6 | 292.5 | 211.7 | 294.6 | 335.0 | 207.7 | 178.0 | 1.5 | 0 | 0 | 0 | 0 |
| Gross Profit | 196.7 | 97.0 | 120.5 | 270.0 | 130.2 | 230.7 | 189.7 | 200.1 | 177.4 | (114.2) | (0.1) | (23.3) | 0 | 0 |
| Operating Income | 23.5 | (50.5) | (46.3) | (80.8) | (264.5) | (377.8) | (286.3) | (178.1) | (79.9) | (136.5) | (61.5) | (37.9) | (15.9) | (8.5) |
| Net Income | (5.3) | (69.4) | (51.9) | (94.2) | (282.0) | (384.8) | (279.7) | (171.9) | (76.9) | (135.7) | (60.7) | (37.0) | (13.2) | (8.2) |
| EPS (Diluted) | -0.02 | -0.33 | -0.28 | -0.58 | -1.48 | -2.53 | -2.36 | -1.47 | -1.77 | -3.60 | -2.29 | -2.40 | -0.68 | -0.81 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 184.8 | 51.9 | 42.9 | 90.5 | 149.8 | 229.1 | 147.7 | 104.6 | 70.2 | 187.3 | ||||
| Total Assets | 376.6 | 220.7 | 241.7 | 356.1 | 529.3 | 644.1 | 771.2 | 996.5 | 364.2 | 300.2 | ||||
| Total Debt | 216.3 | 188.7 | 104.2 | 99.8 | 136.0 | 126.3 | 108.3 | 15 | 0 | 0 | ||||
| Stockholders' Equity | 32.6 | (49.2) | (30.6) | 5.2 | 74.0 | 247.6 | 394.8 | 635.9 | 119.3 | 68.1 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | 68.0 | (40.7) | (23.4) | (73.2) | (253.0) | (110.4) | (257.4) | (97.5) | (56.2) | 57.9 | ||||
| Capital Expenditure | (0.3) | (0.0) | 0 | (0.1) | (0.1) | (0.3) | (6.7) | (1.6) | (1.6) | (2.7) | ||||
| Free Cash Flow | 68.0 | (40.7) | (23.4) | (73.3) | (253.0) | (110.7) | (264.1) | (99.1) | (57.8) | 55.2 | ||||